(1)
Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients With Severe Alopecia Areata. J of Skin 2023, 7 (6), s295. https://doi.org/10.25251/skin.7.supp.295.